Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia

PLoS One. 2016 Mar 2;11(3):e0149970. doi: 10.1371/journal.pone.0149970. eCollection 2016.

Abstract

Objective: Demographic and health surveys, immunization coverage surveys and administrative data often divergently estimate vaccination coverage, which hinders pinpointing districts where immunization services require strengthening. We assayed vaccination coverage in three regions in Ethiopia by coverage surveys and linked serosurveys.

Methods: Households with children aged 12-23 (N = 300) or 6-8 months (N = 100) in each of three districts (woredas) were randomly selected for immunization coverage surveys (inspection of vaccination cards and immunization clinic records and maternal recall) and linked serosurveys. IgG-ELISA serologic biomarkers included tetanus antitoxin ≥ 0.15 IU/ml in toddlers (receipt of tetanus toxoid) and Haemophilus influenzae type b (Hib) anti-capsular titers ≥ 1.0 mcg/ml in infants (timely receipt of Hib vaccine).

Findings: Coverage surveys enrolled 1,181 children across three woredas; 1,023 (87%) also enrolled in linked serosurveys. Administrative data over-estimated coverage compared to surveys, while maternal recall was unreliable. Serologic biomarkers documented a hierarchy among the districts. Biomarker measurement in infants provided insight on timeliness of vaccination not deducible from toddler results.

Conclusion: Neither administrative projections, vaccination card or EPI register inspections, nor parental recall, substitute for objective serological biomarker measurement. Including infants in serosurveys informs on vaccination timeliness.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Capsules / immunology
  • Biomarkers / blood*
  • Diphtheria-Tetanus-Pertussis Vaccine / immunology
  • Ethiopia
  • Female
  • Haemophilus Vaccines / immunology
  • Health Surveys / methods
  • Humans
  • Immunization / methods
  • Immunization Programs / methods
  • Immunization Schedule
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Infant
  • Male
  • Parents
  • Vaccination / methods

Substances

  • Biomarkers
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Haemophilus Vaccines
  • Haemophilus influenzae type b polysaccharide vaccine
  • Immunoglobulin G

Grants and funding

This work was supported by Bill & Melinda Gates Foundation Grant OPP1017350. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JSI Research & Training Institute Inc. provided support in the form of salaries for authors (ZA, LO, JS, RS). Other than these authors, JSI did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors (ZA, LO, JS, RS) are articulated in the "author contributions" section.